Innova Captab Limited - chemicals in Thane, Maharashtra, India. FY 2026 financials & compliance.
CIN L24246MH2005PLC150371 Incorporated 03 January 2005 ROC Mumbai HQ Thane, Maharashtra, India
Active Listed Public Limited Company chemicals
Data last updated
Market Cap
₹6,684 Cr
INNOVACAP · NSE
Share Price
₹1,168.00
+0.71% today
Revenue
₹1,630 Cr
FY 2025-26 · +31.2% YoY
EBITDA
₹243 Cr
Margin 14.9%
Net Profit
₹140 Cr
FY 2025-26 · +9.3% YoY
P/E (TTM)
43.1x
P/B 6.1x
ROE
13.8%
ROCE 14.9%
Debt / Equity
0.33
Interest cover 8.6x

About Innova Captab Limited

Data last updated:

Innova Captab Limited is a public limited company based in Thane, Maharashtra, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 03 January 2005 and has been in existence for over 21 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L24246MH2005PLC150371. Its GSTIN is 27AABCH5082R1ZZ (Maharashtra). The company holds 8 GST registrations, of which 6 are active. It is a listed company.

The company has an authorised share capital of ₹66 Cr and a paid-up capital of ₹57.22 Cr. It was formerly known as Innova Captab Private Limited and Harun Health Care Private Limited. It is led by directors including Vinay Kumar Lohariwala (Managing Director) and Jayant Vasudeo Rao (Whole-Time Director).

Its last annual general meeting (AGM) was held on 31 July 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Thane, Maharashtra.

As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹1,630.02 Cr, a growth of 31.06% compared to the previous year. The net worth stands at ₹1,090.8 Cr (up 13.69% YoY). Total assets are valued at ₹1,446.4 Cr (up 10.63% YoY).

The company has about 1,246 employees on its provident fund (EPFO) records. Its group structure includes 2 subsidiaries.

The company is associated with 1 brand: Innova Captab. As per MCA filings, the company has open charges of ₹505.32 Cr and satisfied charges of ₹158.4 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website innovacaptab.com.

Company Details of Innova Captab Limited
CIN L24246MH2005PLC150371
Registration Number 150371
Incorporation Date 03 January 2005
ROC Mumbai
Listing Status Listed
Company Status Active
Date of Last AGM 31 July 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
    Locked
  • Registered Address
    1513 15th Floor Satra Plaza Chs Ltd., Plot No. 19 & 20 Sector – 19D Vashi Navi Mumbai, Thane, Maharashtra, India – 400703
  • Industry
    Chemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
Comprehensive company report
Innova Captab Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Innova Captab Limited report

Financials, compliance, directors, charges, ownership and filings for Innova Captab Limited in one report.

10-year financials Directors & ownership Charges & compliance

Name History of Innova Captab

Innova Captab has undergone 2 name changes throughout its history. The company was previously known as Innova Captab Private Limited, and Harun Health Care Private Limited. The current legal name is Innova Captab Limited.

Company NameStatus
Innova Captab LimitedCurrent
Innova Captab Private LimitedPrevious
Harun Health Care Private LimitedPrevious

CIN History of Innova Captab

Innova Captab has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L24246MH2005PLC150371, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
L24246MH2005PLC150371Current
U24246MH2005PTC150371Previous
U24246MH2005PLC150371Previous

Associated Brands with Innova Captab

Innova Captab operates one associated brand: Innova Captab. Each brand links to its own profile.

BrandDescriptionWebsite
Pharmaceutical formulations are manufactured by Innova Captab as a CDMO.innovacaptab.com

Competitors & Alternatives of Innova Captab

Brands and companies operating in the same space as Innova Captab Limited include Pharmaron, Pfizer, Lonza and 6 more.

CompetitorDescriptionLocationFounded
Pharmaron Pharmaron Drug discovery and development services for small molecules are provided.Beijing, China, China2003
Pfizer Pfizer Pharmaceutical products for treating multiple diseases are provided.New York, United States, United States1849
Lonza Lonza CDMO services for pharma, biotech, and specialty ingredients are provided.Basel, Switzerland, Switzerland1897
Dotmatics Dotmatics AI powered scientific data management and workflow automation solutions-2005
Boehringer Ingelheim Boehringer Ingelheim Generic drugs and clinical research services are provided globally.-1885
LabConnect LabConnect Laboratory testing, clinical trial research, and biopharma services are provided.Johnson City, United States, United States2002
Beta Drugs Beta Drugs Developer of therapeutics for oncology and dermatologyPanchkula, India, India2005
Ainos Ainos Novel point-of-care testing and low-dose interferon therapeutics are developed.San Diego, United States, United States1986
Biomatter Biomatter Provider of synthetic biology and AI-based technology for generative protein designVilnius, Lithuania, Lithuania2018

Business Activity of Innova Captab

The main business activity of Innova Captab is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
Premium access

Business activity turnover details for Innova Captab Limited

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Innova Captab

Innova Captab Limited is audited by B S R AND Co. LLP for the financial year 2025.

NameStatusAppointment DateCessation Date
B S R AND Co. LLPLockedLockedLocked
Premium access

Complete auditor history for Innova Captab Limited

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Innova Captab Limited

Innova Captab has 8 current directors and 18 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Jayant Vasudeo RaoWhole-Time Director22 Nov 20178 Years 10 MonthsCurrent
Shirish Gundopant BelapureDirector01 Apr 20224 Years 6 MonthsCurrent
Sudhir Kumar BassiDirector01 Apr 20224 Years 6 MonthsCurrent
Priyanka DixitDirector01 Apr 20224 Years 6 MonthsCurrent
Archit AggarwalDirector01 Apr 20224 Years 6 MonthsCurrent
Manoj Kumar LohariwalaWhole-Time Director03 Jun 200917 Years 4 MonthsCurrent
Showing 6 of 8 current directors. View all directors

Financials of Innova Captab Limited FY 2025-26 filings available

Innova Captab Limited reported revenue of ₹1,630.02 Cr (up 31.06% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹1,630 Cr
+31.1% YoY
EBITDA
₹243 Cr
+30.5% YoY
Profit After Tax
₹140 Cr
+9.3% YoY
Net Worth
₹1,091 Cr
+13.7% YoY
Total Assets
₹1,446 Cr
+10.6% YoY
Total Debt
₹344 Cr
+1.6% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue1,6301,2441,081926801411373
Revenue growth+31.2%+14.1%+14.0%+15.4%+97.8%+10.5%+2.3%
EBITDA24318615411496.0254.4850.93
EBITDA margin+14.9%+15.0%+14.3%+12.3%+12.0%+13.3%+13.6%
Profit before tax18817113091.7985.7246.3337.52
Net profit14012894.3266.2863.9634.3727.87
Net profit margin+8.6%+10.3%+8.7%+7.2%+8.0%+8.4%+7.5%
EPS (₹)24.6322.4116.4914.16532.94287.50232.38
Balance sheet
Total assets1,4461,3071,085524410192165
Net worth1,091959831323209145110
Total debt34433824519019945.5054.07
Cash & bank3.8768.1786.7518.882.4411.895.18
Net working capital51543634926621694.4592.77
Cash flow
Cash from operations11763.8414667.1258.9041.5730.80
Cash from investing(107)(152)(499)(90.84)(188)(19.67)(6.04)
Cash from financing(21.72)91.5336127.09125(19.34)(23.28)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue471448450380352315316318
Revenue growth (YoY)+33.9%+42.3%+42.3%+19.5%+19.5%+19.8%+4.6%+12.5%
Other income2.011.561.654.194.483.384.332.22
EBITDA73.1265.0969.3951.8652.1047.6846.5649.73
EBITDA margin+15.5%+14.5%+15.4%+13.6%+14.8%+15.1%+14.7%+15.6%
Depreciation11.7111.3911.4211.3211.059.805.134.99
Interest4.434.593.955.502.861.950.170.15
Profit before tax58.9950.6755.6739.2342.6739.3145.5946.81
Tax14.8612.5913.539.5711.679.7411.3911.81
Net profit44.1338.0842.1429.6631.0029.5734.2035.00
EPS (₹)7.716.657.375.185.425.175.976.12
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue1,299958865859785411373
Revenue growth+37.3%+10.4%-0.4%+10.7%+92.9%+10.5%+9997.0%
EBITDA15112210898.5298.5154.4850.93
EBITDA margin+11.7%+12.8%+12.5%+11.5%+12.5%+13.3%+13.6%
Profit before tax11212093.7078.2988.6446.3337.52
Net profit83.6789.5269.5555.8866.1934.3727.87
Net profit margin+6.4%+9.3%+8.0%+6.5%+8.4%+8.4%+7.5%
EPS (₹)14.6315.6311.9111.9955.15287.50232.38
Balance sheet
Total assets1,2151,146970516390192165
Net worth887813724315211145110
Total debt32132924419017645.0354.07
Cash & bank1.9967.8986.3514.992.1911.895.18
Net working capital40032325822016094.3492.77
Cash flow
Cash from operations34.1119.8011239.2858.3441.5730.80
Cash from investing(14.06)(99.75)(472)(87.53)(188)(19.67)(6.04)
Cash from financing(33.99)83.8636851.29125(19.33)(23.28)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue400358364290287243249240
Revenue growth (YoY)+39.6%+47.7%+46.4%+20.7%+26.5%+22.4%+5.1%+13.4%
Other income2.702.683.214.634.324.363.494.28
Total expenses346320317261252214216207
EBITDA54.0538.6447.0029.3234.8228.1832.5033.18
EBITDA margin+13.5%+10.8%+12.9%+10.1%+12.1%+11.6%+13.1%+13.8%
Depreciation9.689.409.419.489.087.813.083.07
Interest4.033.983.475.212.771.870.130.08
Profit before tax43.0427.9437.3319.2627.2922.8632.7834.31
Tax10.976.789.434.937.005.738.378.71

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 04 Oct 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue471448450380352315316318
Revenue growth (YoY)+33.9%+42.3%+42.3%+19.5%+19.5%+19.8%+4.6%+12.5%
Other income2.011.561.654.194.483.384.332.22
EBITDA73.1265.0969.3951.8652.1047.6846.5649.73
EBITDA margin+15.5%+14.5%+15.4%+13.6%+14.8%+15.1%+14.7%+15.6%
Depreciation11.7111.3911.4211.3211.059.805.134.99
Interest4.434.593.955.502.861.950.170.15
Profit before tax58.9950.6755.6739.2342.6739.3145.5946.81
Tax14.8612.5913.539.5711.679.7411.3911.81
Net profit44.1338.0842.1429.6631.0029.5734.2035.00
EPS (₹)7.716.657.375.185.425.175.976.12
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue1,6301,2441,081926801411373
Revenue growth+31.2%+14.1%+14.0%+15.4%+97.8%+10.5%+2.3%
Other income7.4212.0512.499.202.881.371.30
Total expenses1,3871,058927813705356322
Employee cost16711790.6654.8040.4622.3320.24
EBITDA24318615411496.0254.4850.93
EBITDA margin+14.9%+15.0%+14.3%+12.3%+12.0%+13.3%+13.6%
Depreciation45.1824.7815.9611.087.505.5910.08
Interest16.902.4121.4619.975.683.934.63
Profit before tax18817113091.7985.7246.3337.52
Tax47.3542.7635.1823.8421.7711.859.65
Net profit14012894.3266.2863.9634.3727.87
Net profit margin+8.6%+10.3%+8.7%+7.2%+8.0%+8.4%+7.5%
EPS (₹)24.6322.4116.4914.16532.94287.50232.38
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital57.2357.2357.2394.8512.0012.0012.00
Reserves & surplus1,03490277422919713398.35
Shareholders' funds (net worth)1,091959831323209145110
Minority interest0.000.000.000.000.000.000.00
Secured loans34233524116314937.9442.76
Unsecured loans1.962.944.0527.2650.057.5611.31
Total debt34433824519019945.5054.07
Total liabilities1,4461,3071,085524410192165
Assets
Gross block95690140621620510794.26
Net block84283035818318379.1473.16
Capital work in progress15.5022.5234121.540.037.260.00
Investments41.290.000.000.000.000.000.00
Inventories28320814411712891.4565.49
Sundry debtors43733228826521313986.77
Cash & bank balances3.8768.1786.7518.882.4411.895.18
Loans & advances15787.8860.5041.0635.5428.5713.63
Total current assets882696580442379270171
Total current liabilities36726023117616317678.30
Net working capital51543634926621694.4592.77
Total assets1,4461,3071,085524410192165
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash15.5211.733.530.154.802.240.75
Net cash from operating activities11763.8414667.1258.9041.5730.80
Net cash from investing activities(107)(152)(499)(90.84)(188)(19.67)(6.04)
Net cash from financing activities(21.72)91.5336127.09125(19.34)(23.28)
Net change in cash(12.32)3.798.203.37(4.64)2.561.48
Closing cash3.8768.1786.7518.882.4411.895.18
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+31.1%+15.0%+16.7%+15.7%+94.9%+10.0%+4.9%
EBITDA growth+30.5%+20.5%+35.9%+18.4%+76.3%+7.0%+24.9%
PBT growth+10.1%+32.0%+41.1%+7.1%+85.0%+23.5%+51.6%
Net income growth+9.3%+36.1%+42.3%+3.6%+86.1%+23.3%+40.3%
Revenue CAGR (3Y)+20.7%+15.8%+38.1%+35.4%+31.0%--
EBITDA CAGR (3Y)+28.8%+24.7%+41.5%+30.7%+33.0%--
Profitability & leverage
Net income margin+8.6%+10.3%+8.7%+7.3%+8.0%+8.4%+7.5%
Return on capital employed+14.9%+14.5%+18.8%+23.9%+30.4%+28.2%+26.3%
Return on net worth+13.8%+14.3%+17.0%+28.0%+36.2%+27.0%+28.9%
Debt / equity0.330.330.380.730.690.390.65
Long-term debt / equity0.220.250.260.290.210.070.20
Interest cover8.551.4915.5019.476.428.0411.33
Efficiency & per share
Fixed asset turnover1.761.903.474.395.134.094.06
Inventory turnover6.647.078.287.547.285.237.16
Debtors turnover4.244.013.913.884.563.654.20
EPS (₹)24.6322.4116.4914.16532.94287.50232.38
Dividend per share (₹)2.000.000.000.000.000.000.00
Book value per share (₹)190.61167.66145.2057.611,738.381,206.84919.62
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue400358364290287243249240
Revenue growth (YoY)+39.6%+47.7%+46.4%+20.7%+26.5%+22.4%+5.1%+13.4%
Other income2.702.683.214.634.324.363.494.28
Total expenses346320317261252214216207
EBITDA54.0538.6447.0029.3234.8228.1832.5033.18
EBITDA margin+13.5%+10.8%+12.9%+10.1%+12.1%+11.6%+13.1%+13.8%
Depreciation9.689.409.419.489.087.813.083.07
Interest4.033.983.475.212.771.870.130.08
Profit before tax43.0427.9437.3319.2627.2922.8632.7834.31
Tax10.976.789.434.937.005.738.378.71
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue1,299958865859785411373
Revenue growth+37.3%+10.4%-0.4%+10.7%+92.9%+10.5%+9997.0%
Other income13.2416.7810.728.732.861.371.30
Total expenses1,147836757760687356322
Employee cost11162.7450.1143.6036.3022.2220.24
EBITDA15112210898.5298.5154.4850.93
EBITDA margin+11.7%+12.8%+12.5%+11.5%+12.5%+13.3%+13.6%
Depreciation37.3717.0211.4010.667.405.5910.08
Interest15.422.1713.5918.305.333.934.63
Profit before tax11212093.7078.2988.6446.3337.52
Tax28.1430.4225.5320.7522.4611.859.65
Net profit83.6789.5269.5555.8866.1934.3727.87
Net profit margin+6.4%+9.3%+8.0%+6.5%+8.4%+8.4%+7.5%
EPS (₹)14.6315.6311.9111.9955.15287.50232.38
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital57.2357.2357.2394.8512.0012.0012.00
Reserves & surplus82975666622019913398.35
Shareholders' funds (net worth)887813724315211145110
Secured loans31932624016313937.9442.76
Unsecured loans1.952.913.8627.0736.997.0911.31
Total debt32132924419017645.0354.07
Total liabilities1,2151,146970516390192165
Assets
Gross block74569820819518594.9383.23
Net block64863716416116179.1473.15
Capital work in progress15.2721.0233921.540.037.260.00
Investments10160.0060.0060.0060.000.000.00
Inventories20414093.9997.2710591.4565.49
Sundry debtors33024921723017413986.77
Cash & bank balances1.9967.8986.3514.992.1911.895.18
Loans & advances17272.3739.7036.4531.9528.5713.63
Total current assets709529437378313270171
Total current liabilities30920618015815317678.30
Net working capital40032325822016094.3492.77
Total assets1,2151,146970516390192165
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash15.3111.393.140.104.802.230.75
Net cash from operating activities34.1119.8011239.2858.3441.5730.80
Net cash from investing activities(14.06)(99.75)(472)(87.53)(188)(19.67)(6.04)
Net cash from financing activities(33.99)83.8636851.29125(19.33)(23.28)
Net change in cash(13.94)3.928.253.03(4.69)2.561.48
Closing cash1.9967.8986.3514.992.1911.895.18
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+35.6%+10.8%+0.7%+9.3%+91.3%+10.0%+9997.0%
EBITDA growth+23.8%+13.3%+9.6%+0.0%+80.8%+7.0%+9997.0%
PBT growth-6.7%+27.9%+19.7%-11.7%+91.3%+23.5%+9997.0%
Net income growth-6.5%+28.7%+24.5%-15.6%+92.6%+23.3%+9997.0%
Revenue CAGR (3Y)+14.8%+6.9%+28.2%+32.0%---
EBITDA CAGR (3Y)+15.4%+7.5%+25.6%+24.6%---
Profitability & leverage
Net income margin+6.4%+9.3%+7.9%+6.7%+8.4%+8.4%+7.5%
Return on capital employed+10.8%+11.5%+14.4%+21.3%+32.3%+28.2%+25.5%
Return on net worth+9.9%+11.6%+13.7%+24.0%+37.2%+27.0%+25.3%
Debt / equity0.380.370.420.700.620.390.49
Long-term debt / equity0.270.300.290.300.210.070.11
Interest cover13.532.0614.0720.835.858.0411.33
Efficiency & per share
Fixed asset turnover1.802.114.294.525.614.614.49
Inventory turnover7.558.199.048.487.985.235.70
Debtors turnover4.494.113.874.265.033.654.30
EPS (₹)14.6315.6311.9111.9955.15287.50232.38
Dividend per share (₹)2.000.000.000.000.000.000.00
Book value per share (₹)154.94142.06126.4755.90175.691,206.84919.62
Want more history and ratios?
You're viewing the latest exchange-filed financials for Innova Captab Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Innova Captab Limited

Shareholding for the quarter ended Sep 2026: promoters hold 50.90%, foreign institutional investors hold 0.30%, domestic institutional investors hold 20.00% and retail and other public shareholders hold 28.80%.

Promoters: 50.90%DII (Domestic Institutional): 20.00%FII (Foreign Institutional): 0.30%Retail & Others: 28.80%
Sep 2026
QUARTER
50.90% Promoters
20.00% DII (Domestic Institutional)
0.30% FII (Foreign Institutional)
28.80% Retail & Others
Promoter holding - history
Now 50.90% · Sep 2026High 50.90% · Dec 2025Low 50.90% · Dec 2025
49%49.8%50.5%51.3%52%Dec 2025Mar 2026Jun 2026Sep 2026Dec 2025: 50.90%Mar 2026: 50.90%Jun 2026: 50.90%Sep 2026: 50.90%50.90%50.90%
Shareholding trend - last 6 quarters
Sep 2026Jun 2026Mar 2026Dec 2025
Promoters50.90%50.90%50.90%50.90%
Public49.10%49.10%49.10%49.10%

Group Structure of Innova Captab Limited

Innova Captab has 2 subsidiary companies. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.

2
Subsidiary companies
Key Subsidiaries
Company NameCINShares Held
Sharon Bio Medicine LimitedU24110MH1989PLC052251-
Univentis Medicare LimitedU24232MH2015PLC402722-

Showing major subsidiaries. Total: 2.

Charges & Borrowings of Innova Captab

Open charges
₹505.32 Cr
Satisfied charges
₹158.4 Cr
Breakdown by lending institutions
State Bank of India₹235.00 Cr
Hdfc Bank Limited₹222.32 Cr
Yes Bank Limited₹48.00 Cr
Latest charge details
DateLenderAmountStatus
28 Jul 2025Hdfc Bank Limited₹52.32 CrOpen
29 Sep 2022Hdfc Bank Limited₹150 CrOpen
29 Sep 2022Hdfc Bank Limited₹20 CrOpen
31 Aug 2017Yes Bank Limited₹48 CrOpen
01 Nov 2011State Bank of India₹235 CrOpen

Total charge records: 17 View all charges

Employees and EPFO Compliance at Innova Captab

Innova Captab Limited has a workforce of 1,246 employees as of Jan 09, 2026.

Employee count
1,246
Active EPFO establishments
2
Employee growth
-1.74%
Premium access

Employee and EPFO history for Innova Captab Limited

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Innova Captab

Innova Captab has 8 GST registrations: 6 active and 2 cancelled or inactive. The first 4 active GSTINs are listed below.

Total GSTINs
8
Active
6
Cancelled / inactive
2
GSTINStateStatusRegistered on
27AABCH5082R1ZZMaharashtraActive25 Oct 2023
02AABCH5082R2ZAHimachal PradeshActive01 Jul 2017
01AABCH5082R1ZDJammu and KashmirActive24 Mar 2022
06AABCH5082R1Z3HaryanaActive01 Jul 2022
Premium access

GST registrations and filing compliance for Innova Captab Limited

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Innova Captab

Premium access

Credit ratings, litigation, and regulatory alerts for Innova Captab Limited

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Innova Captab

Premium access

MSME payment history for Innova Captab Limited

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Innova Captab

Premium access

Corporate group structure for Innova Captab Limited

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Innova Captab

Premium access

MCA filings and documents for Innova Captab Limited

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Innova Captab

Charges
07 Feb 2026
A charge with State Bank Of India of Rs. 235.00 Cr registered on 01 Nov 2011 with Charge ID 10320494 was modified on 07 Feb 2026.
Charges
16 Dec 2025
A charge with Yes Bank Limited of Rs. 48.00 Cr registered on 31 Aug 2017 with Charge ID 100123200 was modified on 16 Dec 2025.
Charges
04 Oct 2025
A charge with Hdfc Bank Limited of Rs. 150.00 Cr registered on 29 Sep 2022 with Charge ID 100621143 was modified on 04 Oct 2025.
Charges
02 Sep 2025
A charge with Hdfc Bank Limited of Rs. 52.32 Cr registered on 28 Jul 2025 with Charge ID 101135336 was modified on 02 Sep 2025.
Activity
31 Jul 2025
Innova Captab Limited last Annual general meeting of members was held on 31 Jul 2025 as per latest MCA records.
Charges
28 Jul 2025
A charge with Hdfc Bank Limited amounted to Rs. 52.32 Cr with Charge ID 101135336 was registered on 28 Jul 2025.

Frequently Asked Questions about Innova Captab Limited

Innova Captab is an active public limited company based in Thane, Maharashtra, India. The company works in chemical products, within the chemicals industry. It was incorporated on 03 January 2005 (21+ years old) and is registered under CIN L24246MH2005PLC150371.

Innova Captab reported revenue of ₹1,630.02 Cr for FY 2025-26 (up 31.06% YoY) based on consolidated financials.

Innova Captab has 8 current directors:

The GSTIN of Innova Captab is 27AABCH5082R1ZZ, registered in Maharashtra. The company has 8 GST registrations in all, of which 6 are active and 2 are cancelled or inactive. Other active GSTINs include 02AABCH5082R2ZA (Himachal Pradesh), 01AABCH5082R1ZD (Jammu and Kashmir), 06AABCH5082R1Z3 (Haryana).

The CIN (Corporate Identification Number) of Innova Captab is L24246MH2005PLC150371. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes, Innova Captab is a listed company.

Innova Captab was incorporated on 03 January 2005, making it 21+ years old. It is registered with the Registrar of Companies, Mumbai.

Innova Captab can be reached through the website innovacaptab.com. Its registered office is in Thane, Maharashtra, India.

The registered office of Innova Captab is at 1513 15th Floor Satra Plaza Chs Ltd., Plot No. 19 & 20 Sector – 19D Vashi Navi Mumbai, Thane, Maharashtra, India – 400703.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available